Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
Friday, February 22, 2013 - 10:38am
tags:
Achillion, AbbVie, JNJ, Gilead, Bristol-Myers Squibb
Regulators Await Gilead's Hep C Candidate
Seeking Alpha
Thursday, February 21, 2013 - 6:39pm
tags:
Gilead, hepatitis C, sofosbuvir
Lyrica matches UCB drug in Pfizer's latest epilepsy trial
Fierce Pharma
Thursday, February 21, 2013 - 12:34pm
tags:
Lyrica, UCB, epilepsy, Pfizer, Keppra
J&J’s Floyd Says Hip Sales Halted for Business, Not Safety
Bloomberg
Thursday, February 21, 2013 - 12:29pm
tags:
JNJ, hip implants
Advaxis Vs. Inovio: A Head To Head Comparison Of 2 Cervical Cancer Vaccines
Seeking Alpha
Thursday, February 21, 2013 - 12:16pm
tags:
cervical cancer, vaccines, Advaxis, Inovio, ADXS11-001, HPV, ADXS-HPV, VGX-3100
Repros Therapeutics gets FDA go-ahead on testosterone drug study
Reuters
Thursday, February 21, 2013 - 12:10pm
tags:
FDA, testosterone, Repros Therapeutics, Androxal
Celgene's New Acquisition -- of Celgene
Motley Fool
Thursday, February 21, 2013 - 12:09pm
tags:
Celgene, stock buyback
4 Biotech Stock Stars Losing Their Luster
TheStreet.com Stockpkr
Thursday, February 21, 2013 - 12:06pm
tags:
Celgene, Biogen Idec, Life Technologies, Biomarin
U.S. rejection of Novo drug seen temporary but costly
Yahoo/Reuters
Thursday, February 21, 2013 - 12:03pm
tags:
Novo Nordisk, Tresiba, diabetes
11 New Consumer Advocates to Join FDA Advisory Committees in 2013
Regulatory Affairs Professionals Society
Thursday, February 21, 2013 - 12:02pm
tags:
FDA, advisory panels
Ranbaxy Slams Consumers For Seeking Lipitor Recall
Pharmalot
Thursday, February 21, 2013 - 12:00pm
tags:
Ranbaxy, Lipitor, Pfizer
DepoMed Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, February 21, 2013 - 11:57am
tags:
Depomed, earnings
FDA approves new silicone breast implant from Allergan
Reuters
Thursday, February 21, 2013 - 11:56am
tags:
Allergan, FDA, breast implants
Merck: The Most Undervalued Company In Pharma
Seeking Alpha
Thursday, February 21, 2013 - 11:55am
tags:
Merck
Exact Sciences Earnings: Here’s Why Investors are Selling Shares Now
Wall St. Cheat Sheet
Thursday, February 21, 2013 - 11:54am
tags:
EXACT Sciences, earnings
Abbott to work with J&J on genetic test for leukemia drug
Reuters
Thursday, February 21, 2013 - 11:52am
tags:
JNJ, Abbott Labs, ibrutinib, chronic lymphocytic leukemia
Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments
Forbes
Thursday, February 21, 2013 - 11:11am
tags:
anticoagulants, dabigatran, Apixaban
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Yahoo
Thursday, February 21, 2013 - 11:09am
tags:
Immune Pharmaceuticals, ulcerative colitis, bertilimumab
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wednesday, February 20, 2013 - 5:15pm
tags:
JAK inhibitors, Remicade, JNJ, Enbrel, Stelara, Amgen, Humira, AbbVie
Merck, Samsung JV team up on biosimilar medicines
Yahoo/AP
Wednesday, February 20, 2013 - 5:14pm
tags:
Merck, Korea, biosimilars, Samsung Bioepis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.